BIO-TECHNE Corp (TECH)
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Last price
- $72.50
- As of
Kresmion compiles this page from TECH's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
BIO-TECHNE Corp (TECH): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-23.
See the full TECH dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for TECH on one page. Preview it with sample data, then open it live with a free account.
Preview the TECH dossierActive signals for TECH
- mediumosint_event
OSINT: EU Tripartite Social Summit urges stronger labor dialogue, green transition
- mediumosint_event
OSINT: EU Commission Grants Six Cohesion Projects at REGIOSTARS Ceremony
- mediumosint_event
OSINT: CoreWeave shares plunge as CEO decries irrational market and rising debt costs
- mediumosint_event
OSINT: EU Commission Grants Six Cohesion Projects at REGIOSTARS Awards
- mediumosint_event
OSINT: DOE Unveils Process for 45Z Low-Carbon Fuel Production Credit
FREE, NO ACCOUNT
Every signal on TECH, as it fires
You are seeing 5 of 2,752 signals recorded on TECH since 2026-04-29.
The five above landed across 2 days. The other 2747 were recorded on 126 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in TECH (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 09073M104 · 2026Q2 | $69.9M | 0.03% | , |
| CITADEL ADVISORS LLCCUSIP 09073M104 · 2026Q2 | $68.2M | 0.01% | , |
| SOROS FUND MANAGEMENT LLCCUSIP 09073M104 · 2026Q2 | $37.8M | 0.46% | , |
| D. E. Shaw & Co., Inc.CUSIP 09073M104 · 2026Q2 | $16.1M | 0.01% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 09073M104 · 2026Q2 | $4.9M | 0.00% | , |
| Bridgewater Associates, LPCUSIP 09073M104 · 2026Q2 | $1.9M | 0.01% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, TECH
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
TECH against its peers
TECH's operating margin of 20.7% ranks in the 89th percentile of 22 Life Sciences Tools & Services sub-industry peers, fiscal periods ending between 2025-12-27 and 2026-06-30.
| Metric | TECH | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 1.2B USD | 1.2B USD | 50 | 24 |
| Revenue YoY | -0.4% | n/a | n/a | 0 |
| Gross margin | 65.8% | 55.5% | 79 | 11 |
| Operating margin | 20.7% | -6.6% | 89 | 22 |
| Net margin | 15.0% | -5.2% | 78 | 24 |
| Return on equity | 8.6% | -5.5% | 73 | 23 |
| P / E | 62.5x | 42.5x | 68 | 10 |
| 1 year | 22.3% | 29.5% | 34 | 24 |
Peers (24): RGEN, AVTR, TXG, TEM, BRKR, CRL, MEDP, SHC, ADPT, MTD, ABCL, ILMN, WAT, IQV, FTRE, MRVI, DHR, DNA, MLAB, CTKB, OABI, PACB, TMO, CDXS. Left out: A (period gap). Fiscal periods ending between 2025-12-27 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (TECH: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow TECH on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to TECH for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.